ZA200702869B - Mutated amyloid protein - Google Patents
Mutated amyloid proteinInfo
- Publication number
- ZA200702869B ZA200702869B ZA200702869A ZA200702869A ZA200702869B ZA 200702869 B ZA200702869 B ZA 200702869B ZA 200702869 A ZA200702869 A ZA 200702869A ZA 200702869 A ZA200702869 A ZA 200702869A ZA 200702869 B ZA200702869 B ZA 200702869B
- Authority
- ZA
- South Africa
- Prior art keywords
- amyloid protein
- mutated amyloid
- mutated
- protein
- amyloid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004294292 | 2004-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200702869B true ZA200702869B (en) | 2008-07-30 |
Family
ID=36142786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200702869A ZA200702869B (en) | 2004-10-06 | 2005-10-06 | Mutated amyloid protein |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080063636A1 (fr) |
EP (1) | EP1811025A4 (fr) |
JP (1) | JP4776544B2 (fr) |
KR (1) | KR20070100234A (fr) |
CN (1) | CN101052718A (fr) |
AU (1) | AU2005290401A1 (fr) |
BR (1) | BRPI0516279A (fr) |
CA (1) | CA2583431A1 (fr) |
IL (1) | IL182404A0 (fr) |
MX (1) | MX2007004149A (fr) |
NO (1) | NO20072158L (fr) |
NZ (1) | NZ554794A (fr) |
RU (1) | RU2007116346A (fr) |
WO (1) | WO2006038729A1 (fr) |
ZA (1) | ZA200702869B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
CN117903302A (zh) | 2005-11-30 | 2024-04-19 | Abbvie 公司 | 抗-Aβ球聚体抗体,其相关产品,生产所述抗体的方法,所述抗体的应用以及使用方法 |
PL1976877T5 (pl) | 2005-11-30 | 2017-09-29 | Abbvie Inc | Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2486928A1 (fr) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Procédé pour le traitement des amyloses |
CA2796339C (fr) | 2010-04-15 | 2020-03-31 | Abbott Laboratories | Proteines de liaison a la beta amyloide |
CA2808187A1 (fr) | 2010-08-14 | 2012-02-23 | Abbvie Inc. | Proteines de liaison beta-amyloides |
WO2014126225A1 (fr) * | 2013-02-14 | 2014-08-21 | 公立大学法人大阪市立大学 | Souris knock-in |
CN117858892A (zh) | 2021-05-26 | 2024-04-09 | 恢复治疗瑞典公司 | 用于治疗和/或预防蛋白质病的组合物和方法 |
WO2024071361A1 (fr) * | 2022-09-27 | 2024-04-04 | 株式会社カネカ | Méthode d'évaluation d'activité d'inhibition ou de promotion de coagulation contre une protéine coagulante |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338663A (en) * | 1990-08-24 | 1994-08-16 | President And Fellows Of Harvard College | Method of identifying inhibitors of β-protein esterase activity |
JP2003534351A (ja) * | 2000-05-22 | 2003-11-18 | ニュー・ヨーク・ユニヴァーシティー | アミロイドβ及びアミロイド沈着物に対する免疫応答誘導のための、アミロイドβと相同的な、合成の、免疫原性だが非アミロイド原性ペプチド |
CA2466841A1 (fr) * | 2001-11-21 | 2003-06-05 | New York University | Polypeptides immunogenes synthetiques ne formant pas de depots et peptides homologues destines a des repetitions amyloide $g(b), proteine prion, amyline, $g(a)-synucleine, ou polyglutamine pour induction d'une reponse immunitaire a ceux-ci |
US20040091945A1 (en) * | 2002-07-17 | 2004-05-13 | Cheryl Fitzer-Attas | Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease |
-
2005
- 2005-10-06 CA CA002583431A patent/CA2583431A1/fr not_active Abandoned
- 2005-10-06 CN CNA2005800369299A patent/CN101052718A/zh active Pending
- 2005-10-06 AU AU2005290401A patent/AU2005290401A1/en not_active Abandoned
- 2005-10-06 EP EP05793045A patent/EP1811025A4/fr not_active Withdrawn
- 2005-10-06 NZ NZ554794A patent/NZ554794A/en unknown
- 2005-10-06 US US11/664,714 patent/US20080063636A1/en not_active Abandoned
- 2005-10-06 ZA ZA200702869A patent/ZA200702869B/xx unknown
- 2005-10-06 RU RU2007116346/13A patent/RU2007116346A/ru unknown
- 2005-10-06 JP JP2006539359A patent/JP4776544B2/ja active Active
- 2005-10-06 WO PCT/JP2005/018896 patent/WO2006038729A1/fr active Application Filing
- 2005-10-06 MX MX2007004149A patent/MX2007004149A/es unknown
- 2005-10-06 BR BRPI0516279-3A patent/BRPI0516279A/pt not_active IP Right Cessation
- 2005-10-06 KR KR1020077007975A patent/KR20070100234A/ko not_active Application Discontinuation
-
2007
- 2007-04-10 IL IL182404A patent/IL182404A0/en unknown
- 2007-04-26 NO NO20072158A patent/NO20072158L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2005290401A1 (en) | 2006-04-13 |
WO2006038729A1 (fr) | 2006-04-13 |
CA2583431A1 (fr) | 2006-04-13 |
KR20070100234A (ko) | 2007-10-10 |
NO20072158L (no) | 2007-07-05 |
EP1811025A4 (fr) | 2008-02-06 |
BRPI0516279A (pt) | 2008-09-02 |
EP1811025A1 (fr) | 2007-07-25 |
IL182404A0 (en) | 2007-07-24 |
JP4776544B2 (ja) | 2011-09-21 |
MX2007004149A (es) | 2007-09-11 |
NZ554794A (en) | 2010-01-29 |
US20080063636A1 (en) | 2008-03-13 |
JPWO2006038729A1 (ja) | 2008-05-15 |
RU2007116346A (ru) | 2008-11-20 |
CN101052718A (zh) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182404A0 (en) | Mutated amyloid protein | |
GB0514482D0 (en) | Protein | |
GB0417887D0 (en) | Protein | |
GB0416035D0 (en) | Protein | |
GB0401882D0 (en) | Protein | |
GB0413697D0 (en) | Protein | |
GB0401311D0 (en) | Protein | |
GB0402662D0 (en) | Protein | |
GB0402811D0 (en) | Protein | |
GB0403742D0 (en) | Protein | |
GB0403979D0 (en) | Protein | |
GB0404929D0 (en) | Protein | |
GB0405512D0 (en) | Protein | |
GB0405644D0 (en) | Protein | |
GB0408217D0 (en) | Protein | |
GB0408439D0 (en) | Protein | |
GB0408665D0 (en) | Protein | |
GB0409950D0 (en) | Protein | |
GB0413407D0 (en) | Protein | |
GB0413408D0 (en) | Protein | |
GB0413604D0 (en) | Protein | |
GB0400783D0 (en) | Protein | |
GB0400087D0 (en) | Protein | |
GB0414088D0 (en) | Protein | |
GB0400784D0 (en) | Protein |